These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36721334)

  • 21. Adherence, per-protocol effects, and the estimands framework.
    Keene O
    Pharm Stat; 2023; 22(6):1141-1144. PubMed ID: 37477077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction.
    Keene ON
    Pharm Stat; 2019 Jan; 18(1):78-84. PubMed ID: 30370691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimands in practice: Bridging the gap between study objectives and statistical analysis.
    Phillips A; Clark T
    Pharm Stat; 2021 Jan; 20(1):68-76. PubMed ID: 32893473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimands and Complex Innovative Designs.
    Collignon O; Schiel A; Burman CF; Rufibach K; Posch M; Bretz F
    Clin Pharmacol Ther; 2022 Dec; 112(6):1183-1190. PubMed ID: 35253205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimands-A Basic Element for Clinical Trials.
    Pohl M; Baumann L; Behnisch R; Kirchner M; Krisam J; Sander A
    Dtsch Arztebl Int; 2021 Dec; 118(51-52):883-888. PubMed ID: 34857075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development.
    Englert S; Mercier F; Pilling EA; Homer V; Habermehl C; Zimmermann S; Kan-Dobrosky N
    Pharm Stat; 2023; 22(5):921-937. PubMed ID: 37403434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the Estimand Framework to Manage the Disruptive Effects of COVID-19 on Stroke Clinical Trials.
    Yassi N; Hayward KS; Campbell BCV; Churilov L
    Stroke; 2021 Nov; 52(11):3739-3747. PubMed ID: 34587797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice.
    Mallinckrodt CH; Bell J; Liu G; Ratitch B; O'Kelly M; Lipkovich I; Singh P; Xu L; Molenberghs G
    Ther Innov Regul Sci; 2020 Mar; 54(2):353-364. PubMed ID: 32072593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choosing estimands in clinical trials with missing data.
    Mallinckrodt C; Molenberghs G; Rathmann S
    Pharm Stat; 2017 Jan; 16(1):29-36. PubMed ID: 27492760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction meets causal inference: the role of treatment in clinical prediction models.
    van Geloven N; Swanson SA; Ramspek CL; Luijken K; van Diepen M; Morris TP; Groenwold RHH; van Houwelingen HC; Putter H; le Cessie S
    Eur J Epidemiol; 2020 Jul; 35(7):619-630. PubMed ID: 32445007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Principles and recommendations for incorporating estimands into clinical study protocol templates.
    Lynggaard H; Bell J; Lösch C; Besseghir A; Rantell K; Schoder V; Lanius V
    Trials; 2022 Aug; 23(1):685. PubMed ID: 35986349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder.
    Polverejan E; O'Kelly M; Hefting N; Norton JD; Lim P; Walton MK
    Ther Innov Regul Sci; 2023 Sep; 57(5):911-939. PubMed ID: 37244885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
    Mehrotra DV
    Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimand framework: Are we asking the right questions? A case study in the solid tumor setting.
    Casey M; Degtyarev E; Lechuga MJ; Aimone P; Ravaud A; Motzer RJ; Liu F; Stalbovskaya V; Tang R; Butler E; Sailer O; Halabi S; George D
    Pharm Stat; 2021 Mar; 20(2):324-334. PubMed ID: 33155417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the Estimand Framework to Anesthesia Trials.
    De Silva AP; Leslie K; Braat S; Grobler AC
    Anesthesiology; 2024 Jul; 141(1):13-23. PubMed ID: 38743905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimand for non-inferiority influenza vaccine immunogenicity trials.
    Nauta J
    Vaccine; 2024 Feb; 42(4):840-843. PubMed ID: 38220488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causal inference with recurrent and competing events.
    Janvin M; Young JG; Ryalen PC; Stensrud MJ
    Lifetime Data Anal; 2024 Jan; 30(1):59-118. PubMed ID: 37173588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample Size Calculation When Planning Clinical Trials with Intercurrent Events.
    Fang Y; Jin M
    Ther Innov Regul Sci; 2021 Jul; 55(4):779-785. PubMed ID: 33821445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods.
    Olarte Parra C; Daniel RM; Bartlett JW
    Stat Biopharm Res; 2023; 15(2):421-432. PubMed ID: 37260584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dealing with time-dependent exposures and confounding when defining and estimating attributable fractions-Revisiting estimands and estimators.
    Steen J; Morzywołek P; Van Biesen W; Decruyenaere J; Vansteelandt S
    Stat Med; 2024 Feb; 43(5):912-934. PubMed ID: 38122818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.